NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Helix BioPharma Corp (TO: HBP)
HBP Technical Analysis
5
As on 9th Jun 2023 HBP STOCK Price closed @ 0.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.25 & Strong Sell for SHORT-TERM with Stoploss of 0.34 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HBPSTOCK Price
Open | 0.20 | Change | Price | % |
High | 0.20 | 1 Day | -0.01 | -4.76 |
Low | 0.20 | 1 Week | -0.01 | -4.76 |
Close | 0.20 | 1 Month | -0.02 | -9.09 |
Volume | 2000 | 1 Year | -0.29 | -59.18 |
52 Week High 0.54 | 52 Week Low 0.17 |
TO Canada Most Active Stocks
YRI | 7.89 | 0.13% |
CNQ | 75.27 | 0.40% |
UEX | 0.50 | 16.28% |
SU | 40.43 | 0.02% |
SJR-B | 40.48 | 0.02% |
OREA | 0.02 | -77.78% |
VFF | 8.12 | 0.87% |
ENB | 50.62 | -0.80% |
TD | 79.12 | 0.16% |
AC | 22.37 | 0.22% |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
HBP Daily Charts |
HBP Intraday Charts |
Whats New @ Bazaartrend |
HBP Free Analysis |
|
HBP Important Levels Intraday
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
RESISTANCE | 0.20 |
HBP Forecast May 2024
4th UP Forecast | 0.62 |
3rd UP Forecast | 0.49 |
2nd UP Forecast | 0.4 |
1st UP Forecast | 0.32 |
1st DOWN Forecast | 0.08 |
2nd DOWN Forecast | 0 |
3rd DOWN Forecast | -0.09 |
4th DOWN Forecast | -0.22 |
HBP Weekly Forecast
4th UP Forecast | 0.32 |
3rd UP Forecast | 0.28 |
2nd UP Forecast | 0.26 |
1st UP Forecast | 0.23 |
1st DOWN Forecast | 0.17 |
2nd DOWN Forecast | 0.14 |
3rd DOWN Forecast | 0.12 |
4th DOWN Forecast | 0.08 |
HBP Forecast2024
4th UP Forecast | 0.93 |
3rd UP Forecast | 0.7 |
2nd UP Forecast | 0.55 |
1st UP Forecast | 0.41 |
1st DOWN Forecast | -0.01 |
2nd DOWN Forecast | -0.15 |
3rd DOWN Forecast | -0.3 |
4th DOWN Forecast | -0.53 |
Helix BioPharma Corp ( TO Canada Symbol : HBP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HBP Other Details
Segment | EQ | |
Market Capital | 74800480.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
HBP Address
HBP Latest News
HBP Business Profile
Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada. Address: 9120 Leslie Street, Richmond Hill, ON, Canada, L4B 3J9
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service